NASHVILLE, Tenn., Nov. 5, 2024 /PRNewswire/ -- Specialty pharmaceutical company Cumberland Pharmaceuticals (CPIX) today announced the publication of new real-world outcomes research demonstrating the ...
* Cycle Pharmaceuticals receives FDA approval and launches Ketorolac Tromethamine injection 30mg/ml in the U.S. Sign up here. * Cycle Pharmaceuticals receives FDA approval and launches Ketorolac ...
CAMBRIDGE, England--(BUSINESS WIRE)--Cycle Pharmaceuticals Ltd (“Cycle”) is pleased to announce that it has received approval from the U.S. Food and Drug Administration (“FDA”) of its Abbreviated New ...
In adult and pediatric patients, Caldolor reduced ADRs, ER and outpatient visits, and hospital length of stay compared with ketorolac. Topline results were announced from a real-world study comparing ...
– Real World Study Compared Over 150,000 Adult & Pediatric Patients –– Caldolor Associated with Fewer Adverse Drug Reactions –– Caldolor also Improved Healthcare Utilization – This extensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results